「risk」の検索結果

Produces an enforcement-aware Animal Welfare Act compliance audit for USDA/APHIS-regulated facilities. Maps Form 7002 inspection citations to verified 9 C.F.R. Parts 1-3 requirements, analyzes NCI severity and recurrence patterns, evaluates core compliance programs (PVC, IACUC, housing, records, transport), and outputs a prioritized corrective action plan with proof artifacts. Use when auditing AWA compliance, reviewing USDA inspection reports, preparing for license renewal, conducting diligence, or assessing enforcement risk. Trigger: Animal Welfare Act, AWA, USDA, APHIS, Form 7002, IACUC, PVC, exhibitor, dealer, research facility.

日本語の概要は準備中です。原文の説明を表示しています。

China legal triage assistant. Input a contract, labor dispute facts, lawsuit-cost question, or draft legal document need; output risk checklist, cost estimate, evidence outline, or editable document skeleton. Boundary: preliminary legal information only, not a lawyer and not formal legal advice.

日本語の概要は準備中です。原文の説明を表示しています。

Comprehensive legal applications skill covering civil/criminal/administrative litigation workflows, trial defense strategies, legal document drafting (complaints, answers, appeals, retrial petitions, enforcement applications, representation opinions, defense statements, legal opinions, etc.), arbitration (commercial & labor), mediation, enforcement procedures, evidence rules, and litigation risk assessment. Trigger when users ask about: lawsuit/litigation/trial, legal documents, court defense, evidence/cross-examination, arbitration, enforcement, legal strategy, filing a case, appeal, retrial, representation, pleading, or any legal procedural guidance.

日本語の概要は準備中です。原文の説明を表示しています。

Generates structured analytical summaries of appellate documents covering procedural posture, issues on appeal, standards of review, and strategic assessment. Use when onboarding to an appeal, preparing for oral argument, evaluating appellate risk, or summarizing the appellate record.

日本語の概要は準備中です。原文の説明を表示しています。

Extracts technical API constraints from OpenAPI/Swagger specs and developer docs into a contract-ready API Access & Constraints Schedule with source traceability, risk flags, and change-control language. Use when drafting legal exhibits or schedules covering API access scope, rate limits, authentication, data fields, or deprecation terms for MSAs, SOWs, or order forms.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts board-ready Anti-Money Laundering compliance programs for U.S. financial institutions under BSA/FinCEN requirements. Covers CIP, CDD, EDD, SAR/CTR reporting, OFAC screening, risk assessment, training, independent testing, and governance structures. Use when creating or updating AML policies, BSA compliance programs, or financial institution regulatory documentation. Trigger keywords: AML, BSA, FinCEN, Bank Secrecy Act, anti-money laundering, SAR, CTR, OFAC, CIP, CDD, KYC, compliance program.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts U.S. regulatory client advisory summaries translating legal developments into actionable risk and compliance guidance. Use when a client needs a proactive memo, client alert, or legal-update brief for a new law, case, rulemaking, agency guidance, or pending reform. Trigger on requests for "client advisory," "regulatory update," "legal alert," "compliance briefing," "new law summary," or "quarterly advisory."

日本語の概要は準備中です。原文の説明を表示しています。

88查企业风险查询与分析工具 —— 专注于中国大陆企业的法务风险查询与分析，覆盖经营异常、行政处罚、监管措施、被执行人、失信被执行人、司法案件等风险类型。支持公司名称、统一社会信用代码、companyId 三种输入方式，自动完成风险查询并输出结构化风险分析总结。 触发场景：仅当用户意图为查询企业风险/法务风险时触发。包括但不限于：企业风险查询、公司风险、经营异常、行政处罚、监管措施、被执行人、失信被执行人、司法风险、风险扫描、风险评估、企业合规审查、风险报告、XX公司有什么风险、XX公司安全吗、XX公司有没有处罚、XX公司被执行过吗。 不触发场景：纯粹的企业信息查询（如查公司、搜企业、工商信息、注册资本、法人代表、股东结构、专利商标等）不应触发本技能，请使用其他 cha88 系列工具。

日本語の概要は準備中です。原文の説明を表示しています。

欧盟 AI 法案知识引擎——以 70 份官方欧盟来源文件为基础的权威监管问答（包括 2026 年委员会关于 Art. 6 高风险分类的指南草稿——一般原则、附件 I、附件 III）。基于完整条例文本、委员会指南、EDPB/EDPS 意见、《实践守则》、协调标准、FRIA 指南、事件模板和行业特定指引，以条款级引用回答关于 AI 法案的任何问题。当用户询问"EU AI Act"、"AI Act regulation"、"Regulation 2024/1689"、"KI-Verordnung"、要求"explain an AI Act article"、"what does Article X say"、"AI Act requirements"、"AI Act penalties"、"AI Act timeline"、"GPAI obligations"、"high-risk AI"、"prohibited AI practices"、"AI Act and GDPR"、"fundamental rights impact assessment"、"AI Act standards"、"AI Act national implementation"、"AI literacy"、"serious incident reporting"、"Digital Omnibus"、"AI regulatory sandbox"，或任何关于欧盟人工智能监管的问题时，应使用本技能。德语术语同样触发："KI-Gesetz"、"KI-Verordnung"、"Hochrisiko-KI"、"KI-Kompetenz"、"Grundrechte-Folgenabschaetzung"、"GPAI-Verhaltenskodex"。对于产出分类决定而非知识答案的评估工作流，提议在会话内运行结构化风险等级分类。

日本語の概要は準備中です。原文の説明を表示しています。

Vulnerability analysis: OWASP Top 10, current threat landscape, supply chain security, attack surface mapping, risk prioritization. Use for security audits. NOT for STRIDE/CSO infra audits (mk:cso).

日本語の概要は準備中です。原文の説明を表示しています。

Coordinate staged or parallel jobs across coding-agent runtimes and subagents: routes by capability/risk, isolates writers in worktrees, arbitrates results. NOT for a single-agent task (mk:cook).

日本語の概要は準備中です。原文の説明を表示しています。

Validates an approved plan across 8 dimensions before build — incomplete acceptance criteria, missing dependencies, unresolved risks. Use after Gate 1, before Test.

日本語の概要は準備中です。原文の説明を表示しています。

Advanced vulnerability analysis principles. OWASP Top 10 baseline + current threat landscape awareness, Supply Chain Security, attack surface mapping, risk prioritization. Use when performing security audits, threat modeling, or OWASP reviews. NOT for STRIDE/CSO-mode infrastructure audits (see mk:cso).

日本語の概要は準備中です。原文の説明を表示しています。

Validates an approved plan against 8 dimensions before Phase 3 begins. Catches incomplete acceptance criteria, missing dependencies, and unresolved risks. Use after Gate 1 approval and before Phase 2 (Test). Produces a validation report with pass/fail per dimension.

日本語の概要は準備中です。原文の説明を表示しています。

Pre-flight security analysis before code changes — identifies trust boundary risks, dangerous patterns, and provides proceed/caution/block advisory before implementation starts

日本語の概要は準備中です。原文の説明を表示しています。

Audit the code for vulnerabilities, leaked secrets and risky dependencies before it ships.

日本語の概要は準備中です。原文の説明を表示しています。

Handle mental health crisis situations in AI coaching safely. Use when implementing crisis detection, safety protocols, emergency escalation, or suicide prevention features. Activates for crisis keywords, safety planning, hotline integration, and risk assessment.

日本語の概要は準備中です。原文の説明を表示しています。

Analyze bonded agent systems, escrow workflows, slashing rules, oracle trust, Sybil cost, and front-running risk in protocols where agents post bonds or stake reputation. Use for collateral sizing, griefing analysis, dispute design, and bonded-agent security reviews. NOT for smart contract auditing, DeFi tokenomics, blockchain consensus design, or trading strategy.

日本語の概要は準備中です。原文の説明を表示しています。

Bead-based signal normalization and cross-batch harmonization for CyTOF and high-parameter cytometry - EQ four-element bead normalization of instrument sensitivity drift (CATALYST normCytof, premessa), and reference-anchor cross-batch normalization (CytoNorm, per-cluster quantile splines). Covers the distinction between within-run drift correction and between-batch correction, the mandatory anchor/reference sample, why normalization is per-cluster with many quantiles, and the over-correction risk. Use when correcting CyTOF signal drift, harmonizing multi-batch or multi-site studies, or deciding whether to normalize data versus model batch in the design.

日本語の概要は準備中です。原文の説明を表示しています。

Convert between sequence file formats (FASTA, FASTQ, GenBank, EMBL, Stockholm) and re-encode FASTQ quality offsets using Biopython Bio.SeqIO. Use when changing a file format for a downstream tool, fixing FASTQ quality encoding (Phred+33 vs Phred+64 vs Solexa), or when a conversion risks silently dropping annotations or quality scores.

日本語の概要は準備中です。原文の説明を表示しています。

Add p-value brackets, significance asterisks, and effect-size annotations to distribution plots using ggpubr, ggsignif, and statannotations with correct test selection (parametric vs non-parametric vs paired), multiple-testing adjustment, and rendering of negative results. Use when a boxplot/violin/raincloud needs in-figure statistical comparisons between groups.

日本語の概要は準備中です。原文の説明を表示しています。

Runs cis-pQTL Mendelian randomization for drug-target validation using UKB-PPP (Olink), deCODE (SomaScan), Fenland, INTERVAL, ARIC, and FinnGen-PPP proteomes plus colocalization triangulation, phenome-wide on-target adverse-effect scans, cross-platform Olink/SomaScan replication, and PAV (protein-altering variant) sensitivity. Use when nominating or de-risking a drug target from plasma-proteome GWAS, mimicking pharmacological inhibition via cis-pQTL instruments, separating shared-causal from LD-confounded signal under the Schmidt 2020 cis-MR framework, screening on-target adverse phenotypes pheWAS-style, or producing publication-grade STROBE-MR plus PP.H4 evidence for a target gene.

日本語の概要は準備中です。原文の説明を表示しています。

Performs time-to-event analysis for clinical trials including Cox proportional hazards regression with PH diagnostics, restricted mean survival time (RMST) under non-PH, competing risks via Fine-Gray vs cause-specific Cox, weighted log-rank and MaxCombo for non-proportional hazards, recurrent events (Andersen-Gill, PWP, WLW), and interval-censored data. Use when analyzing time-to-event endpoints (OS, PFS, DOR, TTR, TTNT) in oncology or other clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Apply the four published expert-consensus clinical scenarios to manage GI adverse events in complex GLP-1 receptor agonist patients — persistent nausea mid-titration, GERD/heartburn after up-titration, elderly with sarcopenia risk, and insulin-treated elderly with CKD plus diarrhoea. Use when a clinician describes a patient resembling one of these archetypes, or asks "how to manage GLP-1 in an elderly patient with CKD", "patient on liraglutide developed reflux", "sarcopenia worry on semaglutide in 80-year-old", or "persistent nausea on semaglutide despite escalation". Grounded in Gorgojo-Martínez 2023 Table 4.

日本語の概要は準備中です。原文の説明を表示しています。